Advanced search
Publication Cover
Drug, Healthcare and Patient Safety Volume 6, 2014 - Issue
Submit an article Journal homepage
283
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study

Justin T Denholm1 Victorian Infectious Diseases Service, Parkville, VIC, Australia;4 Department of Microbiology and Immunology, University of Melbourne, Parkville, VIC, Australia;5 Victorian Tuberculosis Program, Melbourne Health, Parkville, VIC, AustraliaCorrespondence[email protected]
,
Emma S McBryde1 Victorian Infectious Diseases Service, Parkville, VIC, Australia;3 Department of Medicine (RMH/WH), University of Melbourne, Parkville, VIC, Australia
,
Damon P Eisen1 Victorian Infectious Diseases Service, Parkville, VIC, Australia;3 Department of Medicine (RMH/WH), University of Melbourne, Parkville, VIC, Australia
,
Jocelyn S Penington1 Victorian Infectious Diseases Service, Parkville, VIC, Australia
,
Caroline Chen2 Department of Pharmacy, Royal Melbourne Hospital, Parkville, VIC, Australia
&
Alan C Street1 Victorian Infectious Diseases Service, Parkville, VIC, Australia
Pages 145-149 | Published online: 21 Oct 2014

References

  • DenholmJTMcBrydeESThe use of anti-tuberculosis therapy for latent TB infectionInfect Drug Resist20103637221694895
  • ZwerlingAvan den HofSScholtenJCobelensFMenziesDPaiMInterferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic reviewThorax2012671627021228420
  • FountainFFTolleyEChrismanCRSelfTHIsoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinicChest2005128111612316002924
  • SiskindMSThienemannDKirlinLIsoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literatureNephron19936423033068321366
  • GuptaKBKumarVVishvkarmaSShandilyRIsoniazid-induced alopeciaLung India2011281606121654989
  • DastaJPriorJKurzrokSIsoniazid-induced feverChest1979752196197421557
  • MannBIsoniazid allergyBr Med J19571502068568613404273
  • StreetAMcBrydeESDenholmJTEisenDPManagement of Tuberculosis1st edMelbourneVictorian Infectious Diseases Service2012
  • GrapowMTvon WattenwylRGullerUBeyersdorfFZerkowskiHRRandomized controlled trials do not reflect reality: real-world analyses are critical for treatment guidelines!J Thorac Cardiovasc Surg200613215716798293
  • Hirsch-MovermanYDaftaryAFranksJColsonPWAdherence to treatment for latent tuberculosis infection: systematic review of studies in the US and CanadaInt J Tuberc Lung Dis200812111235125418926033
  • KanBKalinMBruchfeldJCompleting treatment for latent tuberculosis: patient background mattersInt J Tuberc Lung Dis201317559760223575323
  • SaukkonenJJCohnDLJasmerRMAn official ATS statement: hepatotoxicity of antituberculosis therapyAm J Respir Crit Care Med2006174893595217021358

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.